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Abstract
An ancestral polymorphic allele of the human autophagy-related gene IRGM1 is associated with altered gene expression
and a genetic risk for Crohn’s Disease (CD). We used the single nucleotide polymorphism rs10065172C/T as a marker of this
polymorphic allele and genotyped 370 African American and 177 Caucasian tuberculosis (TB) cases and 180 African
American and 110 Caucasian controls. Among African Americans, the TB cases were more likely to carry the CD-related T
allele of rs10065172 (odds ratio of 1.54; 95% confidence interval, 1.17–2.02; P,0.01) compared to controls. Our finding
suggests that this CD-related IRGM1 polymorphic allele is also associated with human susceptibility to TB disease among
African Americans.
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Introduction
Tuberculosis (TB) disease as a result of Mycobacterium tuberculosis
infection is the second deadliest infectious disease worldwide,
causing 1.8 million deaths annually [1]. Development of active TB
disease depends on a complex relationship between the bacterium,
environment, and the host. Importantly, only about 10% of
presumed immunologically normal individuals who are exposed to
M. tuberculosis develop disease. Most infected individuals carry the
bacteria without overt disease for their entire life, a condition
called latent TB infection (LTBI). Among the minority who
progress to TB disease, the molecular mechanisms responsible for
susceptibility to clinical disease are still poorly understood.
Understanding host factors in immunity against the pathogen will
inform efforts to prevent and treat TB disease.
The immunity-related GTPase M (IRGM1) is potentially
important in the host immune response against TB. This protein
is required for immunity against a range of intracellular pathogens
in mice, including Listeria, Toxoplasma, and M. tuberculosis [2,3,4].
However, the role of IRGM1 in humans has been controversial.
The gene appears to have a role in autophagy-dependent
destruction of Mycobacterium bovis (BCG) in cultured human
macrophages [5]. An IRGM1 allele with two single nucleotide
polymorphisms (SNPs, rs13361189 T/C and rs10065172 C/T)
and a 20-kb deletion upstream of the coding region, all in nearly
100% linkage disequilibrium with each other, has been associated
with Crohn’s disease (CD) [6]. This polymorphic allele is also
found to be associated with decreased expression levels in an
immortalized lymphoblastoid cell line [7]. In the current study, we
conducted a case-control study to investigate the association
between this polymorphic IRGM1 allele and human susceptibility
to TB disease.
Methods
A total of 370 African American and 177 Caucasian adult
patients with TB disease without a history of immunosuppressive
conditions or diabetes were identified in the Houston Tuberculosis
Initiative database (10). The mean age was 47.9613.2 yrs, and
70.6% were male. Within this group, 469 had pulmonary TB, 59
had extrapulmonary TB, and 26 had both pulmonary and
extrapulmonary TB. A total of 180 African Americans and 110
Caucasian adults without history of TB, autoimmune disease, or
other infectious diseases were enrolled as controls. All of the
subjects were HIV seronegative.
The study was approved by the Institutional Review Boards of
the Baylor College of Medicine and The Methodist Hospital
Research Institute. After informed consent was obtained, genomic
DNA was obtained from peripheral blood samples of study
subjects using the Nucleon DNA extraction and purification kit
(Amersham International and Scotlab, Buckinghamshire, En-
gland). We used SNP rs10065172 as a marker of the polymorphic
allele in this study. SNP rs10065172 was amplified and sequenced
with a primer pair: 59-TGTCGTACCCAAGCAGAGTG and 39-
GGAGTTTTGCCCACATGTCT and an ABI 3730 XL DNA
analyzer using Big Dye Terminator (PE Applied Biosystems). By
sequencing with two primers, we obtained information for each
sample in duplicate; any incongruous samples were excluded from
the final analysis. All raw data were assembled and analyzed by 2
individuals blinded to the analysis (JH and JL). Genotypic
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contingency tables in Excel and EpiInfo software (P,0.05
considered statistically significant). The power of the study was
calculated to be 37% to detect a 10% difference in allele frequency
with 95% confidence, based on the sample size used.
For RNA analysis, peripheral blood mononuclear cells were
isolated from peripheral blood by Ficoll separation and preserved
in RNA lysis buffer (RNaqueous, Ambion). cDNA was manufac-
tured using random priming and Superscript II reverse transcrip-
tase (Invitrogen). IRGM1 expression was measured by real-time
quantitative PCR using Taqman Assay-on-Demand (Applied
Biosystems). Data were analyzed by 1-way ANOVA in GraphPad
Prism software.
Results
The allele frequencies of the polymorphic allele in test groups
are shown in Figure 1. Among the Caucasian controls, the allele
frequency of rs10065172 was 8.7%, which is similar to the
reported frequencies among Caucasian control groups in previous
studies [8]. Among the Caucasian case group, the allele frequency
of rs10065172 was 10.7%, not significantly different from the
frequency in the control group with odds ratio (OR)=1.27, 95%
confidence interval (CI) 0.71–2.27 (P=0.48). Among African
Americans, the polymorphic allele frequency was 33.4% for
controls, consistent with an intermediate frequency between the
frequency in a Nigerian population and that of a European
Caucasian population according to HapMap (8). However, among
African American cases, the allele frequency of rs10065172 was
43.8%, significantly higher than the control group (OR=1.56;
95% CI, 1.17–2.02; P=0.001) (Figure 1).
Comparison of genotype frequencies between cases and
controls are shown in Table 1. Among African Americans, the
number of individuals who are carriers for the polymorphic allele
(including both those homozygous and heterozygous for the
polymorphic allele) was significantly greater among cases
compared to controls, with odds ratio of 2.30 (95% CI, 1.59–
3.32) (P,0.01). The frequency of the homozygous polymorphic
genotype (TT) was not different, but the frequency of the
homozygous reference genotype (CC) was lower among African
American cases compared to controls, with odds ratio of 0.56
(95% CI, 0.33–0.96) (P,0.05) when expressed relative to the
frequency of the TT genotype. There were no significant
differences in the genotype frequency between Caucasian case
and control groups. The same differences were noted for African
American but not Caucasian study groups when the cases of
pulmonary TB were analyzed separately from the cases of
extrapulmonary TB (data not shown).
In order to investigate the effect of the risk allele on expression
levels of IRGM1, we conducted real-time PCR analysis on cDNA
samples from peripheral blood mononuclear cells, paired with
genotyping of the same cell samples. Among a sample of 76
randomly selected individuals, 5 individuals were homozygous for
the risk allele and 19 were heterozygous. There were no
differences in overall IRGM1 expression level in these peripheral
blood mononuclear cells based on genotype (data not shown).
Discussion
The genomic sequence including SNPs rs13361189 and
rs10065172, as well as a 20-kb deletion/insertion region has been
observed at the same genomic location in the chimpanzee genome,
indicating its ancestral origin [9]. The 39 end of 20-kb deletion is
about 2.7-kb before the reported IRGM1 transcription start; and
the deletion may affect the function of the IRGM1 gene promoter,
causing decreased gene expression [7]. Our data provide the first
evidence of the association between this polymorphic allele of the
autophagy-related gene IRGM1 and human susceptibility to TB
disease.
We noted that the frequency of the IRGM1 polymorphic allele
was higher among African American cases compared to controls;
conversely the homozygous reference genotype (CC) was under-
represented among African American cases. This finding indicates
that the reference allele may be associated with protection again
tuberculosis in this population.
Two recent studies have reported an association between
polymorphisms in the regulatory region of IRGM1 and TB [10],
[11]. A case-control study conducted in China examined a
1.7-kb promoter region of IRGM1 and identified one polymor-
phism, -1208A/G, that was associated with TB susceptibility [10].
Unfortunately, this studied region covered none of the three linked
polymorphisms investigated here: rs13361189, rs10065172, and
the 20-kb deletion/insertion. Another study conducted in a West
African population found that an IRGM1 SNP -261T confers
protection against a Euro-American lineage of M. tuberculosis [11].
However, the CD-related IRGM1 allele (rs10065172) failed to
show a significant association with TB disease in that study
population [11]. There may be several reasons for the discrepancy
between our findings and those of the West African study. For
example, the importance of IRGM1 may be dependent on the
specific strain of M. tuberculosis prevalent in a geographic area.
Indeed, specific mutations in the IRGM1 gene may have differing
degrees of impact according to geographic populations, as has
been reported in previous association studies [12,13]. Our study is
also limited by the inherent genetic heterogeneity within the
African American population; and differences in genetic hetero-
geneity may exist between our case and control groups.
Duplication of this study in another large African American
population would strengthen our findings and would be interesting
to pursue in the future.
Figure 1. The risk allele frequency for SNP rs10065172 is
higher among African Americans with TB disease compared to
unaffected controls. For each group the bar and n are as follows:
Caucasian controls (white) n=110; Caucasian cases (white stripes)
n=177; African American controls (grey) n=180; African American
cases (grey stripes) n=370. Differences (***) are significant (P,0.001) by
chi-squared test.
doi:10.1371/journal.pone.0016317.g001
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level and genotype in peripheral blood mononuclear cells.
Previous studies have indicated that baseline IRGM1 expression
varies significantly according to cell type. Of note, one study
showed that the deletion polymorphism upstream of IRGM1 led to
increased expression in some cell lines (notably, a lymphoblastoid
line) while contributing to decreased expression in other cell lines
(notably, a colon carcinoma cell line) [8]. A limitation of our study
is that the study sample of peripheral blood mononuclear cells
contained a heterogeneous mix of cell types that may have
obscured any phenotypic changes in IRGM1 expression. Further-
more, our small sample size would have been underpowered to
detect small differences in expression.
The allele frequency of the studied IRGM1 allele was found
more commonly in African and Asian populations (55–60%)
compared to Caucasian populations (5%) (http://hapmap.ncbi.
nlm.nih.gov). This data is consistent with the findings in our
previous TB susceptibility studies, in which TB-related alleles of
NRAMP1, IL8, TLR1, TLR6, TLR10, and NOD2 genes are found
more commonly in African and Asian-derived populations
compared to European-derived populations [12,13,14,15].
In summary, our findings indicate that the polymorphic allele of
IRGM1 contributes to susceptibility to TB disease among an
African American population within the United States. Further-
more, these findings strengthen a potential link between
Crohn’s Disease and an infectious etiology through the
process of autophagy-dependent immunity. Irgm1 prevents
interferon-induced cell death among T cells in mice[16]. Hence,
we speculate that IRGM1 similarly participates in regulation of
the interferon-dependent immune response in humans, and that
dysregulation of the gene leads to misdirected immune responses,
manifest as progression to TB disease or Crohn’s disease in various
populations.
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Table 1. Genotypic comparison of IRGM1 rs10065172 between tuberculosis cases and controls.
Caucasians African Americans
Genotypes/Allele
Cases
N=177
Controls
N=110 OR (95%CI)
Cases
N=370
Controls
N=180 OR (95%CI)
CC 140 (79.2%) 92 (83.5%) 1.0 107 (28.9%) 87 (48.3%) 1.0
TT 1 (0.6%) 1 (1%) 1.52 (0.094–24.6) 61 (16.5%) 28 (15.3%) 1.77 (1.04–3.01)
a
CT 36 (20.2%) 17 (15.5%) 0.72 (0.38–1.35) 202 (54.6%) 65 (36.3%) 2.53 (1.70–3.76)
b
CT+TT
(carrier)
37 (20.8%) 18 (16.5%) 0.74 (0.40–1.38) 263 (71.1%) 93 (51.7%) 2.30 (1.59–3.32)
b
Note:
aP,0.05.
bP,0.01.
doi:10.1371/journal.pone.0016317.t001
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